These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 31174610)

  • 21. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
    Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
    Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
    Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
    ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages.
    Ding L; Liang G; Yao Z; Zhang J; Liu R; Chen H; Zhou Y; Wu H; Yang B; He Q
    Oncotarget; 2015 Nov; 6(34):36441-55. PubMed ID: 26497364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization via AKT/mTOR pathway.
    Xiao X; Li Y; Wang Y; Zhang Y; Chen J; Liu W; Tang J; Yue F; Yang J
    Int Immunopharmacol; 2022 Feb; 103():108427. PubMed ID: 34922249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-Tumorigenic Macrophage Infiltration in Oral Squamous Cell Carcinoma and Possible Macrophage-Aimed Therapeutic Interventions.
    Bruna F; Scodeller P
    Front Oncol; 2021; 11():675664. PubMed ID: 34041037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
    Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
    Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
    Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
    J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms.
    Hegab AE; Ozaki M; Kagawa S; Hamamoto J; Yasuda H; Naoki K; Soejima K; Yin Y; Kinoshita T; Yaguchi T; Kawakami Y; Ornitz DM; Betsuyaku T
    Lung Cancer; 2018 May; 119():25-35. PubMed ID: 29656749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth.
    Shan H; Dou W; Zhang Y; Qi M
    Nanoscale; 2020 Nov; 12(43):22268-22280. PubMed ID: 33146206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer.
    Parker CC; Bin Salam A; Song PN; Gallegos C; Hunt A; Yates C; Jaynes J; Lopez H; Massicano AVF; Sorace AG; Fernandez S; Houson HA; Lapi SE
    Mol Pharm; 2023 May; 20(5):2415-2425. PubMed ID: 37014648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
    Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
    Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization of naturally occurring melittin peptide isoforms in two honey bee species, Apis mellifera and Apis cerana.
    Park D; Jung JW; Lee MO; Lee SY; Kim B; Jin HJ; Kim J; Ahn YJ; Lee KW; Song YS; Hong S; Womack JE; Kwon HW
    Peptides; 2014 Mar; 53():185-93. PubMed ID: 24512991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors.
    Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT
    Front Immunol; 2023; 14():1334800. PubMed ID: 38259462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using macrophage activation to augment immunotherapy of established tumours.
    Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
    Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell RNA sequencing reveals recruitment of the M2-like CCL8
    Yang H; Lei Z; He J; Zhang L; Lai T; Zhou L; Wang N; Tang Z; Sui J; Wu Y
    J Transl Med; 2024 Mar; 22(1):306. PubMed ID: 38528587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
    Ge Z; Ding S
    Front Oncol; 2020; 10():590941. PubMed ID: 33224886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic comparison and the potential antitumor function of immortalized bone marrow-derived macrophages (iBMDMs).
    Xie DK; Yao J; Li PH; Zhu YW; Chen JN; Cao XL; Cheng SL; Chen YM; Huang YF; Wang L; Wang ZH; Qiao R; Ge JM; Yue H; Wei L; Liu ZY; Han H; Qin HY; Zhao JL
    Front Immunol; 2024; 15():1379853. PubMed ID: 38650937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
    Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
    Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).
    Ngambenjawong C; Gustafson HH; Pineda JM; Kacherovsky NA; Cieslewicz M; Pun SH
    Theranostics; 2016; 6(9):1403-14. PubMed ID: 27375788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.